Boutique MedTech CRO gains access to unified eClinical platform with wholesale pricing, training, and joint marketing ...

A lung cancer trial bolsters a long-held idea that treatment timing matters, showing a simple shift could help immunotherapy ...

Amgen (NASDAQ:AMGN) today announced the European Commission (EC) has approved UPLIZNA® (inebilizumab) as an add-on treatment to ...

NIH halts arm of clinical trial evaluating a potential stroke treatment: Bethesda, Maryland Thursday, February 12, 2026, 18:00 Hrs [IST] The National Institutes of Health (NIH) ha ...

Semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease regardless of baseline adiposity. Cardiovascular benefit was largely ...

Genetics and lifestyle factors, such as leisure screen time and smoking, may significantly contribute to heart risk in patients with ADHD.

Scroll through social media long enough and a pattern emerges. Pause on a post questioning climate change or taking a hard ...

Excess body weight may help explain why some chronic illnesses frequently occur together, according to a study.

As with randomization, if allocation to the study drug is not carried out in accordance with the protocol, the entire study ...

Neurocrine Biosciences, Inc. ( NBIX) Q4 2025 Earnings Call February 11, 2026 4:30 PM EST ...

CORALreef Lipids randomized 2,909 adults (2:1) to enlicitide 20 mg daily or placebo across 168 sites, using stratification by renal function, baseline statin use, and region. LDL-C at week 24 ...

Q4 2025 Earnings Call February 11, 2026 4:30 PM ESTCompany ParticipantsChad Fugure - Vice President of Investor ...